AI is redefining decision-making in biopharma R&D - pharmaphorum
Target identification is currently the most widely adopted AI use case , with 43% of organisations in our research implementing it and reporting an ...
Read the original at Pharmaphorum ↗
- Topics
- Healthcare
- Tracked via
- “AI Use Case”